This study is intended to develop and evaluate a novel, highly water-soluble polymer drug conjugate poly(l-γ-glutamyl-l-carbocisteine)-paclitaxel (PGSC-PTX) which can trigger drug release in tumor acidic microenvironment and improve the therapeutic index of paclitaxel (PTX). PGSC-PTX is formed by introducing an additional carbocisteine into each glutamic side chain of poly(l-glutamic acid)-paclitaxel (PGA-PTX) conjugate. PGSC-PTX self-assembles into nanoparticles, whose size remains in the range of 15-20nm. PGSC-PTX demonstrated sensitive to pH and released PTX rapidly in low pH. PGSC-PTX shows significant in vitro cytotoxicity to NH460 cancer cell line, which has less toxic and side effect of than PTX. Meanwhile, the hemolytic test indicated that the nanoparticles could be used for intravenous injection. It was concluded that the maximum tolerated dose of PGSC-PTX achieved to be 250mg PTX/kg, which is extremely maximum tolerated providing a significant foundation in the clinical research.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.msec.2017.07.032 | DOI Listing |
J Pediatr Hematol Oncol
January 2025
MVR Cancer Centre and Research Institute, Calicut, Kerala, India.
Background And Aims: Chemotherapy with alternating cycles of vincristine-doxorubicin-cyclophosphamide and ifosfamide-etoposide, along with primary tumor treatment with surgery or radiotherapy or both, constitute the usual treatment of Ewing sarcoma. The AEWS0031 study demonstrated survival benefits after interval-compressed chemotherapy without significant toxicity. The aim of this study was to assess the tolerability of dose-intensified chemotherapy in developing countries like India.
View Article and Find Full Text PDFStat Med
February 2025
MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
There is a growing number of Phase I dose-finding studies that use a model-based approach, such as the CRM or the EWOC method to estimate the dose-toxicity relationship. It is common to assume that all patients will have similar toxicity risk given the dose regardless of patients' individual characteristics. In many trials, however, some patients' covariates (e.
View Article and Find Full Text PDFStat Med
February 2025
Medical University of South Carolina, Charleston, South Carolina, USA.
This manuscript derives the allocation predictability measured by the correct guess probability and the probability of being deterministic for individual treatment assignments, as well as the averages of a randomization sequence, based on the treatment imbalance transition matrix and the conditional allocation probability. The methods described are applicable to restricted randomization designs that satisfy the following criteria: (1) two-arm equal allocation, (2) restriction of maximum tolerated imbalance, and (3) conditional allocation probability fully determined by the observed current treatment imbalance. Analytical results indicate that, for two-arm equal allocation trials, allocation predictability alternates by the odd/even sequence order of the treatment assignment.
View Article and Find Full Text PDFJ Plant Res
January 2025
Graduate School of Life Sciences, Tohoku University, Aoba, Sendai, 980-8578, Japan.
Since photosynthesis is highly sensitive to salinity stress, remote sensing of photosynthetic status is useful for detecting salinity stress during the selection and breeding of salinity-tolerant plants. To do so, photochemical reflectance index (PRI) is a potential measure to detect conversion of the xanthophyll cycle in photosystem II. Raphanus sativus var.
View Article and Find Full Text PDFCells
January 2025
Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
Although immune checkpoint blockade (ICB) therapy has attained unprecedented clinical success, the tolerance and immune suppression mechanisms evolved by tumor cells and their tumor microenvironment (TME) hinder its maximum anti-cancer potential. Ferroptosis therapy can partially improve the efficacy of ICB, but it is still subject to immune suppression by myeloid-derived suppressor cells (MDSCs) in the TME. Recent research suggests that an MDSC blockade can unleash the full therapeutic potential of the combined therapy of ferroptosis and ICB in liver cancer treatment.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!